Screener
Organon OGN Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Organon in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Organon’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 8:46 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029532
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Contingencies (Note 15) | ||
| Organon & Co. Stockholders’ Equity: | ||
| Common stock, $0.01 par valueAuthorized - 500,000Issued and outstanding - 262,649 in 2026 and 260,316 in 2025 | 3 | 3 |
| Additional paid-in capital | 186 | 167 |
| Retained earnings | 1,253 | 1,109 |
| Accumulated other comprehensive loss | (539) | (527) |
| Total Stockholders’ Equity | 903 | 752 |
| Total Liabilities and Stockholders’ Equity | $12,996 | $12,867 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Organon's total liabilities & equity?
- Organon (OGN) reported total liabilities & equity of $13B in Q1 2026.
- How has Organon's total liabilities & equity changed year-over-year?
- Organon's total liabilities & equity decreased by 1.2% year-over-year, from $13.16B to $13B.
- What is the long-term trend for Organon's total liabilities & equity?
- Over 5 years (2020 to 2025), Organon's total liabilities & equity has grown at a 4.9% compound annual growth rate (CAGR), from $10.11B to $12.87B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Organon's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude